Literature DB >> 30988047

Bioavailability of oral curcumin.

Amit X Garg1, Louise Moist1, Neesh Pannu2, Sheldon Tobe3, Michael Walsh4, Matthew Weir5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30988047      PMCID： PMC6464885          DOI： 10.1503/cmaj.71719

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

2.  Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial.

Authors:  Amit X Garg; P J Devereaux; Andrew Hill; Manish Sood; Bharat Aggarwal; Luc Dubois; Swapnil Hiremath; Randolph Guzman; Vikram Iyer; Matthew James; Eric McArthur; Louise Moist; George Ouellet; Chirag R Parikh; Virginia Schumann; Sumit Sharan; Heather Thiessen-Philbrook; Sheldon Tobe; Ron Wald; Michael Walsh; Matthew Weir; Neesh Pannu
Journal:  CMAJ       Date:  2018-10-29       Impact factor: 8.262

3.  Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting.

Authors:  Wanwarang Wongcharoen; Sasivimon Jai-Aue; Arintaya Phrommintikul; Weerachai Nawarawong; Surin Woragidpoonpol; Thitipong Tepsuwan; Apichard Sukonthasarn; Nattayaporn Apaijai; Nipon Chattipakorn
Journal:  Am J Cardiol       Date:  2012-04-03       Impact factor: 2.778

4.  Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.

Authors:  Matthew A Weir; Michael Walsh; Meaghan S Cuerden; Jessica M Sontrop; Laura C Chambers; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2018-12-05
  5 in total
  3 in total

1.  Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking.

Authors:  Xiaojuan Tong; Sumei Xu; Dong Zhai
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-26       Impact factor: 2.650

2.  Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus.

Authors:  Xiao-Yan Cui; Xiao Wu; Dan Lu; Dan Wang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

3.  Network pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia.

Authors:  Tingting Fang; Lanqin Liu; Wenjun Liu
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.